Studying whether adding dexmedetomidine to ropivacaine in a nerve block (suprainguinal fascia iliaca block) improves pain control after femur fracture surgery.

Assessment of the effect of DEXMEDETOMIDINE as an adjuvant for ROPIVACAINE in suprainguinal facia iliaca compartment block for femur fixation surgeries. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098608

Enrollment

Registered

2025-12-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ultrasound guided suprainguinal facia iliaca compartment block.: The supra inguinal facia iliaca compartment block is a safe and simple block performed under ultrasound guidance where t

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiologists (ASA)Status 1 to 3 Patients posted for femur fixation surgery.

Exclusion criteria

Exclusion criteria: 1. Refusal to participate. 2. BMI more than 45Kg/m2. 3. History of heart failure/ renal failure/ liver failure. 4. Contraindication for spinal anaesthesia. 5. Allergy to local anaesthetics. 6. Prior surgery in the inguinal or suprainguinal area. 7. Pregnancy. 8. On chronic opioid therapy. 9. Prior history of myocardial infarction.

Design outcomes

Primary

Measure	Time frame
To determine the time to first rescue analgesia.Timepoint: 0 hours to 24 hours	—

Secondary

Measure	Time frame
1. VAS scores on arrival to PACU and every 4 hours for 24 hours. 2. Presence or absence of quadriceps weakness during mobilisation. 3. Ability to participate in mobilisation. 4.Total anaelgesic consumption in 24 hours.Timepoint: 15 minutes, 30 minutes, 1,2,4,8,12,24 hours	—

Countries

India

Contacts

Public ContactDr Mahesh Vakamudi

Sri Ramachandra Institute of Higher Education and Research

vakamudi@gmail.com9840022626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026